News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) H1 2014 Results - Interview With Chris Viehbacher


7/31/2014 9:22:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS, July 31, 2014 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014. Chris Viehbacher, CEO of Sanofi, comments on results and outlook.

Watch video interview and read transcript:

http://eurobusinessmedia.com/ceo-direct/sanofi/interview-with-ceo-chris-viehbacher-h1-2014-results,2014-07-30,1235?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include:

  • Q2 2014

  • FY 2014

  • Diabetes

  • Genzyme

  • Vaccines

  • Alirocumab

  • Animal Health

  • CHC

  • R&D

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris /quotes/zigman/187276/delayed FR:SAN +2.72% and in New York /quotes/zigman/307926/delayed/quotes/nls/sny SNY +1.13% .

SOURCE Sanofi

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES